<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="164847">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01958697</url>
  </required_header>
  <id_info>
    <org_study_id>AG-BMI</org_study_id>
    <nct_id>NCT01958697</nct_id>
  </id_info>
  <brief_title>Age and Gender Corrected Body Mass Index</brief_title>
  <official_title>Age and Gender Corrected Body Mass Index: When Preoperative Weight Loss and Underweight Are Becomming Clinically Significant in Esophagectomy for Cancer.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Gasthuisberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Gasthuisberg</source>
  <oversight_info>
    <authority>Belgium: Federal Agency for Medicines and Health Products, FAMHP</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Esophagectomy for cancer is often accompanied with severe preoperative weight loss. Body
      Mass Index (BMI) values are age-independent and the same for both sexes. From the
      perspective that these two parameters should actually be taken into account too, we
      developed a model to calculate &quot;age-gender specific BMI-percentiles&quot; (AG-BMI) and tested
      this model in relation to survival outcome after esophagectomy for cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Age-Gender specific BMI percentiles are more accurate compared to the current BMI classes in
      predicting Overall Survival (OS) after esophagectomy for cancer. Furthermore we believe in a
      more devastating impact on OS from underweight and not from overweight.

      By preoperatively identifying risk patients for poorer OS, especially the non-tumoral
      deaths, this can be a tool to tailor postoperative nutritional strategies to counter further
      weight loss and bringing postoperative weight to normal ranges.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>Overall 5 year survival</measure>
    <time_frame>5 years after esophagectomy</time_frame>
    <safety_issue>No</safety_issue>
    <description>Overall 5-year survival after esophagectomy for cancer</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">650</enrollment>
  <condition>Esophageal Cancer</condition>
  <arm_group>
    <arm_group_label>AG-BMI &lt; 10 pct</arm_group_label>
    <description>Patients who's peroperative BMI is less than the 10th centile</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AG-BMI &gt;= 10th pct</arm_group_label>
    <description>Patients who's peroperative BMI equals or is greater than the 10th centile</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Esophageal cancer patients recieving an esophagectomy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  any type of esophagectomy

        Exclusion Criteria:

          -  Preoperative organ metastasis (cM+ or yM+)

          -  esophageal bypass surgery
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Univresity Hospital Leuven - dept. Thoracic Surgery</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 7, 2013</lastchanged_date>
  <firstreceived_date>October 7, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Gasthuisberg</investigator_affiliation>
    <investigator_full_name>Johnny Moons</investigator_full_name>
    <investigator_title>Datamanager Thoracic Surgery</investigator_title>
  </responsible_party>
  <keyword>Nutritional Disorders</keyword>
  <keyword>Feeding Behavior</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Esophageal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
